GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (NYSE:BIO.B) » Definitions » Cyclically Adjusted Revenue per Share

Bio-Rad Laboratories (Bio-Rad Laboratories) Cyclically Adjusted Revenue per Share : $92.47 (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Bio-Rad Laboratories Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bio-Rad Laboratories's adjusted revenue per share for the three months ended in Mar. 2024 was $21.404. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $92.47 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Bio-Rad Laboratories's average Cyclically Adjusted Revenue Growth Rate was 2.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 5.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 4.70% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 3.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Bio-Rad Laboratories was 11.60% per year. The lowest was 2.10% per year. And the median was 7.20% per year.

As of today (2024-05-22), Bio-Rad Laboratories's current stock price is $279.91. Bio-Rad Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $92.47. Bio-Rad Laboratories's Cyclically Adjusted PS Ratio of today is 3.03.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bio-Rad Laboratories was 9.77. The lowest was 1.59. And the median was 3.48.


Bio-Rad Laboratories Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Bio-Rad Laboratories's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Rad Laboratories Cyclically Adjusted Revenue per Share Chart

Bio-Rad Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.46 78.72 82.71 88.72 94.06

Bio-Rad Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 90.86 92.74 94.51 94.06 92.47

Competitive Comparison of Bio-Rad Laboratories's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Bio-Rad Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Rad Laboratories's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bio-Rad Laboratories's Cyclically Adjusted PS Ratio falls into.



Bio-Rad Laboratories Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bio-Rad Laboratories's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=21.404/131.7762*131.7762
=21.404

Current CPI (Mar. 2024) = 131.7762.

Bio-Rad Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 18.453 100.560 24.181
201409 18.210 100.428 23.894
201412 20.458 99.070 27.212
201503 16.143 99.621 21.354
201506 17.225 100.684 22.544
201509 15.964 100.392 20.955
201512 19.328 99.792 25.523
201603 15.970 100.470 20.946
201606 17.465 101.688 22.633
201609 17.146 101.861 22.182
201612 19.171 101.863 24.801
201703 16.718 102.862 21.417
201706 16.819 103.349 21.445
201709 17.774 104.136 22.492
201712 20.604 104.011 26.104
201803 18.280 105.290 22.879
201806 19.058 106.317 23.622
201809 17.996 106.507 22.266
201812 20.419 105.998 25.385
201903 18.402 107.251 22.610
201906 18.990 108.070 23.156
201909 18.794 108.329 22.862
201912 20.616 108.420 25.057
202003 18.931 108.902 22.907
202006 17.861 108.767 21.639
202009 21.484 109.815 25.780
202012 26.129 109.897 31.331
202103 24.077 111.754 28.391
202106 23.747 114.631 27.299
202109 24.717 115.734 28.143
202112 24.214 117.630 27.126
202203 23.388 121.301 25.408
202206 23.196 125.017 24.450
202209 22.897 125.227 24.095
202212 24.603 125.222 25.891
202303 22.753 127.348 23.544
202306 23.203 128.729 23.752
202309 21.631 129.860 21.950
202312 23.661 129.419 24.092
202403 21.404 131.776 21.404

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Bio-Rad Laboratories  (NYSE:BIO.B) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bio-Rad Laboratories's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=279.91/92.47
=3.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bio-Rad Laboratories was 9.77. The lowest was 1.59. And the median was 3.48.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bio-Rad Laboratories Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Rad Laboratories (Bio-Rad Laboratories) Business Description

Traded in Other Exchanges
Address
1000 Alfred Nobel Drive, Hercules, CA, USA, 94547
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas, Europe and Africa , and Asia-Pacific. Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

Bio-Rad Laboratories (Bio-Rad Laboratories) Headlines